Literature DB >> 27442857

Current State and Future Perspectives of Energy Sources for Totally Implantable Cardiac Devices.

Peter A Bleszynski1, Jessica G Y Luc, Peter Schade, Steven J PhilLips, Vakhtang Tchantchaleishvili.   

Abstract

There is a large population of patients with end-stage congestive heart failure who cannot be treated by means of conventional cardiac surgery, cardiac transplantation, or chronic catecholamine infusions. Implantable cardiac devices, many designated as destination therapy, have revolutionized patient care and outcomes, although infection and complications related to external power sources or routine battery exchange remain a substantial risk. Complications from repeat battery replacement, power failure, and infections ultimately endanger the original objectives of implantable biomedical device therapy - eliminating the intended patient autonomy, affecting patient quality of life and survival. We sought to review the limitations of current cardiac biomedical device energy sources and discuss the current state and trends of future potential energy sources in pursuit of a lifelong fully implantable biomedical device.

Entities:  

Mesh:

Year:  2016        PMID: 27442857     DOI: 10.1097/MAT.0000000000000412

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  2 in total

Review 1.  Continuous-flow left ventricular assist device systems infections: current outcomes and management strategies.

Authors:  Nana Aburjania; Christine M Hay; Muhammad R Sohail
Journal:  Ann Cardiothorac Surg       Date:  2021-03

2.  Management and outcomes of left ventricular assist device-associated endocarditis: a systematic review.

Authors:  Sinal Patel; Syed Saif Abbas Rizvi; Jae Hwan Choi; Dylan P Horan; Matthew P Weber; Elizabeth J Maynes; Jessica G Y Luc; Nana Aburjania; John W Entwistle; Rohinton J Morris; Howard T Massey; Vakhtang Tchantchaleishvili
Journal:  Ann Cardiothorac Surg       Date:  2019-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.